New patent for Taiho Oncology drug LYTGOBI

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for LYTGOBI
Annual Drug Patent Expirations for LYTGOBI

Lytgobi is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

This drug has forty patent family members in twenty-one countries.

The generic ingredient in LYTGOBI is futibatinib. One supplier is listed for this compound. Additional details are available on the futibatinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top